Tvardi Therapeutics (TVRD) Receivables - Other (2015 - 2025)
Tvardi Therapeutics (TVRD) reported Receivables - Other of $1.01 million for Q1 2025, up 99.4% from $506,000 a year earlier but down 75.3% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Receivables - Other (2015 - 2025) Analysis & Trends
At the end of FY2024, Tvardi Therapeutics posted Receivables - Other of $4.09 million, up 636.6% from FY2023.
- Receivables - Other has increased for three consecutive years, with a five-year compound annual growth rate of 33.3% (FY2019 to FY2024).
- By year, Receivables - Other came in at $555,000 in FY2023 (+11.9%), $496,000 in FY2022 (+9.0%), $455,000 in FY2021 (-18.3%) and $557,000 in FY2020 (-42.6%).
- Five-year quarterly Receivables - Other spans a low of $305,000 in Q2 2021 and a high of $20.35 million in Q3 2021.
- Year over year, Receivables - Other gained in four of the last eight quarters, with growth averaging 57.9%.
- The high point for year-over-year Receivables - Other in five years was Q4 2024 (growth of 636.6%); the low point was Q2 2024 (a decline of 92.5%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $4.09 million (Q4 2024), $934,000 (Q3 2024) and $764,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | -95.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 934,000.00 |
| Jun 30, 2024 | 764,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | 555,000.00 |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 10.12 Mn |
| Mar 31, 2023 | 6.07 Mn |
| Dec 31, 2022 | 496,000.00 |
| Sep 30, 2022 | 9.62 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 455,000.00 |
| Sep 30, 2021 | 20.35 Mn |
| Jun 30, 2021 | 305,000.00 |
| Mar 31, 2021 | 2.24 Mn |
| Dec 31, 2020 | 557,000.00 |
| Sep 30, 2020 | 462,000.00 |
| Jun 30, 2020 | 486,000.00 |
API Access
Tvardi Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();